LeonaBio (LONA) Long-Term Investments (2020 - 2023)

LeonaBio (LONA) has reported Long-Term Investments for 4 consecutive years, with $10.2 million the latest figure, recorded in Q2 2023.

• In Q2 2023, Long-Term Investments fell 65.77% year-over-year to $10.2 million; the TTM figure through Jun 2023 stood at $10.2 million (down 65.77% YoY), while the FY2022 annual figure was $44.8 million, down 32.01% from the prior year.
• Long-Term Investments retreated to $10.2 million in Q2 2023 per LONA's latest filing, from $33.9 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $103.6 million in Q3 2021 and bottomed at $10.2 million in Q2 2023.
• Historically, Long-Term Investments has averaged $50.1 million across 4 years, with a median of $41.9 million in 2022.
• Annual changes were most pronounced in 2021 — Long-Term Investments jumped 207.97% — and 2023, when it sank 65.77%.
• LeonaBio's Long-Term Investments stood at $83.5 million in 2020, then declined by 21.04% to $65.9 million in 2021, then tumbled by 32.01% to $44.8 million in 2022, then sank by 77.21% to $10.2 million in 2023.
• Business Quant data shows LONA's Long-Term Investments at $10.2 million in Q2 2023, $33.9 million in Q1 2023, and $44.8 million in Q4 2022.